The Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, United States; Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, United States
Kelly A Marshall
The Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, United States
Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, United States
Reshma R Desai
Department of Pharmacology, Feinberg School of Medicine, Northwestern University, Chicago, United States
Bernabe I Bustos
The Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, United States
Brandon N Piyevsky
The Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, United States
Juan A Ortega
The Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, United States
Marc Forrest
Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, United States; Center for Autism and Neurodevelopment, Feinberg School of Medicine, Northwestern University, Chicago, United States
Gabriella L Robertson
The Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, United States
Peter Penzes
Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, United States; Center for Autism and Neurodevelopment, Feinberg School of Medicine, Northwestern University, Chicago, United States
Linda C Laux
Epilepsy Center and Division of Neurology, Departments of Pediatrics and Neurology, Ann & Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago, United States
The Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, United States
John J Millichap
Epilepsy Center and Division of Neurology, Departments of Pediatrics and Neurology, Ann & Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago, United States
The Ken & Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, United States; Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, United States
Mutations in KCNQ2, which encodes a pore-forming K+ channel subunit responsible for neuronal M-current, cause neonatal epileptic encephalopathy, a complex disorder presenting with severe early-onset seizures and impaired neurodevelopment. The condition is exceptionally difficult to treat, partially because the effects of KCNQ2 mutations on the development and function of human neurons are unknown. Here, we used induced pluripotent stem cells (iPSCs) and gene editing to establish a disease model and measured the functional properties of differentiated excitatory neurons. We find that patient iPSC-derived neurons exhibit faster action potential repolarization, larger post-burst afterhyperpolarization and a functional enhancement of Ca2+-activated K+ channels. These properties, which can be recapitulated by chronic inhibition of M-current in control neurons, facilitate a burst-suppression firing pattern that is reminiscent of the interictal electroencephalography pattern in patients. Our findings suggest that dyshomeostatic mechanisms compound KCNQ2 loss-of-function leading to alterations in the neurodevelopmental trajectory of patient iPSC-derived neurons.